TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative
drug products based on its patented Thin Film Freezing technology platform, today announced that CEO Harlan Weisman, M.D. will attend and hold one-on-one investor meetings at the upcoming Jones
Trading 2023 Healthcare Summit. Dr. Weisman will also present and hold one-on-one investor meetings at the upcoming Roth MKM 2023 Healthcare Opportunities Conference.
Jones Trading 2023 Healthcare Summit – October 9-11, 2023 | |||
Format: | One-on-one investor meetings | ||
Date/Time: | Tuesday, October 10, 2023, from 8:00 - 5:00 pm ET | ||
Participant: | Harlan Weisman, M.D., Chief Executive Officer | ||
Location: | Eden Roc Miami Beach, Miami Beach, FL | ||
Link: | Register here | ||
Roth MKM 2023 Healthcare Opportunities Conference – October 12, 2023 | |||
Format: | Corporate Presentation and one-on-one investor meetings | ||
Date/Time: | Thursday, October 12, 2023, at 9:30 am ET | ||
Participant: | Harlan Weisman, M.D., Chief Executive Officer | ||
Location: | Tap Room, 3rd Floor, The Yale Club, New York City | ||
Link: | Register here |
Lesen Sie auch
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte